Mingxia Bi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mingxia Bi has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Shuang-Jiang Liu
State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China
5 shared publications - Chang Liu
State Key Laboratory of Microbial Technology, Shandong University, Qingdao, PR China
2 shared publications - Yulin Wang
State Key Laboratory of Microbial Technology Shandong University Qingdao China
2 shared publications Chang Liu
State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, PR China
1 shared publication- Chang Liu1 shared publication
Chang-Yu Wang
School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, PR China
1 shared publication
Latest Publications
- Open Access
- 30 April 2025
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 75 (4) , 006767
Flavonifractor porci sp. nov. and Flintibacter porci sp. nov., two novel butyrate-producing bacteria of the family Oscillospiraceae
Two Gram-stain-negative, strictly anaerobic, non-motile, non-spore-forming and rod-shaped bacterial strains, namely, P01024T and P01025T, were isolated from piglet manure. The strains P01024T and P01025T fermented glucose to acetate and butyrate. The major cellular fatty acids (>10.0%) of strain P01024T were C14 : 0, C16 : 0 and summed feature 9 (iso-C17:1 ω9c and/or 10-Methyl-C16:0) and of strain P01025T were C14 : 0, C16 : 0 and summed feature 3 (C16 : 1 ω6c and/or C16 : 1 ω7c). Analysis of 16S rRNA gene sequences indicated that strains P01024T and P01025T belonged to the family Oscillospiraceae. The strain P01024T showed high identities of 16S rRNA genes to type species Flavonifractor plautii ATCC 29863T (96.64%). The highest percentages of conserved protein (POCP) value between strain P01024T and Flavonifractor plautii ATCC 29863T was 59.84%. The average nt identity (ANI) and digital DNA–DNA hybridization (dDDH) values between strain P01024T and Flavonifractor plautii ATCC 29863T were 79.51% and 23.80%, respectively, supporting that strain P01024T represented a novel species of the genus Flavonifractor. Strain P01025T showed high identities of 16S rRNA genes to the type species Flintibacter butyricus BLS21T (95.87%). The highest POCP and AAI (average aa identity) values of strains P01025T to Flintibacter hominis New-19T were 53.02% and 73.11%, respectively. The ANI and dDDH values between strains P01025T and Flintibacter hominis New-19T were 75.44% and 23.40%, respectively, supporting that strain P01025T represented a novel species in the genus Flintibacter. The calculated G+C molar contents for strains P01024T and P01025T were 58.43 and 56.44 mol%, respectively. Together with phenotypic features, we concluded that strains P01024T and P01025T represented novel species in the genera Flavonifractor and Flintibacter of the family Oscillospiraceae, respectively, for which the names Flavonifractor porci sp. nov. (type strain P01024T=CGMCC 1.18055T=KCTC 25793T) and Flintibacter porci sp. nov. (type strain P01025T=CGMCC 1.18060T=KCTC 25794T) are proposed.
- 30 April 2025
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 75 (4) , 006767
Open AccessFlavonifractor porci sp. nov. and Flintibacter porci sp. nov., two novel butyrate-producing bacteria of the family Oscillospiraceae
Two Gram-stain-negative, strictly anaerobic, non-motile, non-spore-forming and rod-shaped bacterial strains, namely, P01024T and P01025T, were isolated from piglet manure. The strains P01024T and P01025T fermented glucose to acetate and butyrate. The major cellular fatty acids (>10.0%) of strain P01024T were C14 : 0, C16 : 0 and summed feature 9 (iso-C17:1 ω9c and/or 10-Methyl-C16:0) and of strain P01025T were C14 : 0, C16 : 0 and summed feature 3 (C16 : 1 ω6c and/or C16 : 1 ω7c). Analysis of 16S rRNA gene sequences indicated that strains P01024T and P01025T belonged to the family Oscillospiraceae. The strain P01024T showed high identities of 16S rRNA genes to type species Flavonifractor plautii ATCC 29863T (96.64%). The highest percentages of conserved protein (POCP) value between strain P01024T and Flavonifractor plautii ATCC 29863T was 59.84%. The average nt identity (ANI) and digital DNA–DNA hybridization (dDDH) values between strain P01024T and Flavonifractor plautii ATCC 29863T were 79.51% and 23.80%, respectively, supporting that strain P01024T represented a novel species of the genus Flavonifractor. Strain P01025T showed high identities of 16S rRNA genes to the type species Flintibacter butyricus BLS21T (95.87%). The highest POCP and AAI (average aa identity) values of strains P01025T to Flintibacter hominis New-19T were 53.02% and 73.11%, respectively. The ANI and dDDH values between strains P01025T and Flintibacter hominis New-19T were 75.44% and 23.40%, respectively, supporting that strain P01025T represented a novel species in the genus Flintibacter. The calculated G+C molar contents for strains P01024T and P01025T were 58.43 and 56.44 mol%, respectively. Together with phenotypic features, we concluded that strains P01024T and P01025T represented novel species in the genera Flavonifractor and Flintibacter of the family Oscillospiraceae, respectively, for which the names Flavonifractor porci sp. nov. (type strain P01024T=CGMCC 1.18055T=KCTC 25793T) and Flintibacter porci sp. nov. (type strain P01025T=CGMCC 1.18060T=KCTC 25794T) are proposed.
- Open Access
Limosilactobacillus reuteri Alleviates Anxiety-like Behavior and Intestinal Symptoms in Two Stressed Mouse Models
Background/Objectives: Limosilactobacillus (Lm.) reuteri is a widely utilized probiotic, recognized for its significant role in alleviating symptoms associated with gastrointestinal and psychiatric disorders. However, the effectiveness of Lm. reuteri is strain-specific, and its genetic diversity leads to significant differences in phenotypes among different strains. This study aims to identify potential probiotic strains by comparing the strain-specific characteristics of Lm. reuteri to better understand their efficacy and mechanisms in alleviating stress-induced anxiety-like behaviors and gastrointestinal symptoms. Methods: We cultivated 11 strains of Lm. reuteri from healthy human samples and conducted phenotypic and genomic characterizations. Two strains, WLR01 (=GOLDGUT-LR99) and WLR06, were screened as potential probiotics and were tested for their efficacy in alleviating anxiety-like behavior and intestinal symptoms in mouse models subjected to sleep deprivation (SD) and water avoidance stress (WAS). Results: The results showed that the selected strains effectively improved mouse behaviors, including cognitive impairment and inflammatory response, as well as improving anxiety and regulating gut microbiota composition. The improvements with WLR01 were associated with the regulation of the NLRP3 inflammasome pathway in the SD model mice and were associated with visceral hypersensitivity and intestinal integrity in the WAS model mice. Conclusions: In summary, this study identified the Lm. reuteri strain WLR01 as having the potential to alleviate anxiety-like behavior and intestinal symptoms through the analysis of Lm. reuteri genotypes and phenotypes, as well as validation in mouse models, thereby laying the foundation for future clinical applications.
Open AccessLimosilactobacillus reuteri Alleviates Anxiety-like Behavior and Intestinal Symptoms in Two Stressed Mouse Models
Background/Objectives: Limosilactobacillus (Lm.) reuteri is a widely utilized probiotic, recognized for its significant role in alleviating symptoms associated with gastrointestinal and psychiatric disorders. However, the effectiveness of Lm. reuteri is strain-specific, and its genetic diversity leads to significant differences in phenotypes among different strains. This study aims to identify potential probiotic strains by comparing the strain-specific characteristics of Lm. reuteri to better understand their efficacy and mechanisms in alleviating stress-induced anxiety-like behaviors and gastrointestinal symptoms. Methods: We cultivated 11 strains of Lm. reuteri from healthy human samples and conducted phenotypic and genomic characterizations. Two strains, WLR01 (=GOLDGUT-LR99) and WLR06, were screened as potential probiotics and were tested for their efficacy in alleviating anxiety-like behavior and intestinal symptoms in mouse models subjected to sleep deprivation (SD) and water avoidance stress (WAS). Results: The results showed that the selected strains effectively improved mouse behaviors, including cognitive impairment and inflammatory response, as well as improving anxiety and regulating gut microbiota composition. The improvements with WLR01 were associated with the regulation of the NLRP3 inflammasome pathway in the SD model mice and were associated with visceral hypersensitivity and intestinal integrity in the WAS model mice. Conclusions: In summary, this study identified the Lm. reuteri strain WLR01 as having the potential to alleviate anxiety-like behavior and intestinal symptoms through the analysis of Lm. reuteri genotypes and phenotypes, as well as validation in mouse models, thereby laying the foundation for future clinical applications.
- Open Access
- 12 July 2024
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 74 (7) , 006449
Acutalibacter caecimuris sp. nov., Acutalibacter intestini sp. nov. and Neglectibacter caecimuris sp. nov., three novel species of the family Oscillospiraceae isolated from caecal contents of C57BL/6J mice
The intestines of mice are colonized by diverse, as-yet-uncultivated bacteria. In this report, we describe the isolation, culture, genotypic and phenotypic characterization, as well as taxonomic classification of three novel anaerobic bacterial strains derived from the caecal contents of C57BL/6J male mice. According to the phenotypic and genotype-based polyphasic taxonomy, we propose three novel species within the family Oscillospiraceae. They are Acutalibacter caecimuris sp. nov. (type strain M00118T=CGMCC 1.18042T=KCTC 25739T), Acutalibacter intestini sp. nov. (type strain M00204T=CGMCC 1.18044T=KCTC 25741T) and Neglectibacter caecimuris sp. nov. (type strain M00184T=CGMCC 1.18043T=KCTC 25740T).
- 12 July 2024
- Published by Microbiology Society in International Journal of Systematic and Evolutionary Microbiology
- Vol. 74 (7) , 006449
Open AccessAcutalibacter caecimuris sp. nov., Acutalibacter intestini sp. nov. and Neglectibacter caecimuris sp. nov., three novel species of the family Oscillospiraceae isolated from caecal contents of C57BL/6J mice
The intestines of mice are colonized by diverse, as-yet-uncultivated bacteria. In this report, we describe the isolation, culture, genotypic and phenotypic characterization, as well as taxonomic classification of three novel anaerobic bacterial strains derived from the caecal contents of C57BL/6J male mice. According to the phenotypic and genotype-based polyphasic taxonomy, we propose three novel species within the family Oscillospiraceae. They are Acutalibacter caecimuris sp. nov. (type strain M00118T=CGMCC 1.18042T=KCTC 25739T), Acutalibacter intestini sp. nov. (type strain M00204T=CGMCC 1.18044T=KCTC 25741T) and Neglectibacter caecimuris sp. nov. (type strain M00184T=CGMCC 1.18043T=KCTC 25740T).
- Open Access
- 8 June 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (6) , 1527
Therapeutic Prospect of New Probiotics in Neurodegenerative Diseases
Increasing clinical and preclinical evidence implicates gut microbiome (GM) dysbiosis as a key susceptibility factor for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). In recent years, neurodegenerative diseases have been viewed as being driven not solely by defects in the brain, and the role of GM in modulating central nervous system function via the gut–brain axis has attracted considerable interest. Encouraged by current GM research, the development of new probiotics may lead to tangible impacts on the treatment of neurodegenerative disorders. This review summarizes current understandings of GM composition and characteristics associated with neurodegenerative diseases and research demonstrations of key molecules from the GM that affect neurodegeneration. Furthermore, applications of new probiotics, such as Clostridium butyricum, Akkermansia muciniphila, Faecalibacterium prausnitzii, and Bacteroides fragilis, for the remediation of neurodegenerative diseases are discussed.
- 8 June 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (6) , 1527
Open AccessTherapeutic Prospect of New Probiotics in Neurodegenerative Diseases
Increasing clinical and preclinical evidence implicates gut microbiome (GM) dysbiosis as a key susceptibility factor for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). In recent years, neurodegenerative diseases have been viewed as being driven not solely by defects in the brain, and the role of GM in modulating central nervous system function via the gut–brain axis has attracted considerable interest. Encouraged by current GM research, the development of new probiotics may lead to tangible impacts on the treatment of neurodegenerative disorders. This review summarizes current understandings of GM composition and characteristics associated with neurodegenerative diseases and research demonstrations of key molecules from the GM that affect neurodegeneration. Furthermore, applications of new probiotics, such as Clostridium butyricum, Akkermansia muciniphila, Faecalibacterium prausnitzii, and Bacteroides fragilis, for the remediation of neurodegenerative diseases are discussed.
- Open Access
- 10 May 2023
- Published by MDPI AG in Preprints.org
Next Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic Perspective
Increasing clinical and preclinical evidences implicate gut microbiome (GM) dysbiosis as a key susceptibility factor for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s diseases (PD). In recent years, neurodegenerative diseases have not been viewed as driven solely by defects in brain, and the role of GM in modulating the central nervous system function via gut-brain axis has attracted considerable interest. Encouraged by GM researches, the next-generation probiotics may lead to tangible impacts on the treatment of neurodegenerative disorders. This review summarizes the current understandings of GM composition and characteristics associated with neurodegenerative diseases, and the demonstrations of molecules from GM affecting neurodegeneration. Particularly, applications of next-generation probiotics such as Clostridium butyricum, Akkermansia muciniphila, Faecalibacterium prausnitzii, and Bacteroides fragilis for remediation of neurodegenerative diseases are discussed.
- 10 May 2023
- Published by MDPI AG in Preprints.org
Open AccessNext Generation Probiotics Relevance to Neurodegenerative Diseases: Novel Therapeutic Perspective
Increasing clinical and preclinical evidences implicate gut microbiome (GM) dysbiosis as a key susceptibility factor for neurodegenerative disorders, including Alzheimer’s disease (AD) and Parkinson’s diseases (PD). In recent years, neurodegenerative diseases have not been viewed as driven solely by defects in brain, and the role of GM in modulating the central nervous system function via gut-brain axis has attracted considerable interest. Encouraged by GM researches, the next-generation probiotics may lead to tangible impacts on the treatment of neurodegenerative disorders. This review summarizes the current understandings of GM composition and characteristics associated with neurodegenerative diseases, and the demonstrations of molecules from GM affecting neurodegeneration. Particularly, applications of next-generation probiotics such as Clostridium butyricum, Akkermansia muciniphila, Faecalibacterium prausnitzii, and Bacteroides fragilis for remediation of neurodegenerative diseases are discussed.
- Open Access
- 26 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (4) , 809
Deubiquitylase OTUD3 Mediates Endoplasmic Reticulum Stress through Regulating Fortilin Stability to Restrain Dopaminergic Neurons Apoptosis
OTU domain-containing protein 3 (OTUD3) knockout mice exhibited loss of nigral dopaminergic neurons and Parkinsonian symptoms. However, the underlying mechanisms are largely unknown. In this study, we observed that the inositol-requiring enzyme 1α (IRE1α)-induced endoplasmic reticulum (ER) stress was involved in this process. We found that the ER thickness and the expression of protein disulphide isomerase (PDI) were increased, and the apoptosis level was elevated in the dopaminergic neurons of OTUD3 knockout mice. These phenomena were ameliorated by ER stress inhibitor tauroursodeoxycholic acid (TUDCA) treatment. The ratio of p-IRE1α/IRE1α, and the expression of X-box binding protein 1-spliced (XBP1s) were remarkably increased after OTUD3 knockdown, which was inhibited by IRE1α inhibitor STF-083010 treatment. Moreover, OTUD3 regulated the ubiquitination level of Fortilin through binding with the OTU domain. OTUD3 knockdown resulted in a decrease in the interaction ability of IRE1α with Fortilin and finally enhanced the activity of IRE1α. Taken together, we revealed that OTUD3 knockout-induced injury of dopaminergic neurons might be caused by activating IRE1α signaling in ER stress. These findings demonstrated that OTUD3 played a critical role in dopaminergic neuron neurodegeneration, which provided new evidence for the multiple and tissue-dependent functions of OTUD3.
- 26 March 2023
- Published by MDPI AG in Antioxidants
- Vol. 12 (4) , 809
Open AccessDeubiquitylase OTUD3 Mediates Endoplasmic Reticulum Stress through Regulating Fortilin Stability to Restrain Dopaminergic Neurons Apoptosis
OTU domain-containing protein 3 (OTUD3) knockout mice exhibited loss of nigral dopaminergic neurons and Parkinsonian symptoms. However, the underlying mechanisms are largely unknown. In this study, we observed that the inositol-requiring enzyme 1α (IRE1α)-induced endoplasmic reticulum (ER) stress was involved in this process. We found that the ER thickness and the expression of protein disulphide isomerase (PDI) were increased, and the apoptosis level was elevated in the dopaminergic neurons of OTUD3 knockout mice. These phenomena were ameliorated by ER stress inhibitor tauroursodeoxycholic acid (TUDCA) treatment. The ratio of p-IRE1α/IRE1α, and the expression of X-box binding protein 1-spliced (XBP1s) were remarkably increased after OTUD3 knockdown, which was inhibited by IRE1α inhibitor STF-083010 treatment. Moreover, OTUD3 regulated the ubiquitination level of Fortilin through binding with the OTU domain. OTUD3 knockdown resulted in a decrease in the interaction ability of IRE1α with Fortilin and finally enhanced the activity of IRE1α. Taken together, we revealed that OTUD3 knockout-induced injury of dopaminergic neurons might be caused by activating IRE1α signaling in ER stress. These findings demonstrated that OTUD3 played a critical role in dopaminergic neuron neurodegeneration, which provided new evidence for the multiple and tissue-dependent functions of OTUD3.